Cure My Disease

Don't miss your cure!

 Log in / Sign up

Fava bean peptides put to the test for aging muscles

NCT ID NCT07858292

Symptom relief Sponsor: Universidade Cesumar (UNICESUMAR) Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Oct 05, 2026 · Last updated Oct 08, 2026 · Updated 3 times

Summary

Researchers are testing whether a daily supplement of peptides from fava beans, combined with supervised resistance training, can improve muscle mass, strength, and physical function in adults aged 60 and older. Participants are grouped by whether they are physically active or inactive, then randomly assigned to receive either the fava bean peptides or a placebo. Everyone does the same supervised strength training three times a week for four weeks. The study measures changes in body composition, muscle power, balance, mobility, frailty, mental health, quality of life, and thinking skills.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
peptides derived from fava beans (Vicia faba L.)
What this could lead to
If it works, fava bean peptides could become a simple, low-cost supplement that helps older adults build muscle and stay functional alongside strength training.
What could go wrong
This is a short four-week study in a modest number of older adults, so any muscle or strength changes may be small and could fade without continued training. The supplement may add nothing beyond the exercise itself.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 77 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Nov 2026

An estimate. Start dates often move.

Expected to finish

Jan 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 60 years or older; * Classification as physically active or physically inactive according to the criteria established in the study; * Clinical and functional conditions compatible with participation in the assessments and resistance training program; * Availability to participate in the activities scheduled throughout the intervention period; * Provision of written informed consent. Exclusion Criteria: * Musculoskeletal injuries or conditions that prevent or compromise the safe performance of physical assessments or resistance training; * Acute or uncontrolled clinical or psychiatric conditions that may compromise participant safety or adherence to the study protocol; * Neurodegenerative diseases associated with relevant functional or cognitive impairment; * Use of restrictive diets that may interfere with dietary intake or body composition outcomes; * Use of medications specifically intended for weight loss; * Regular use of ergogenic supplements with the potential to interfere with the muscular or metabolic adaptations investigated in the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Healthy aging are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Healthy aging

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • UniCesumar - Centro Universitário Cesumar

    Maringá, Paraná, 87050-900, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.